Current views on diagnosis, treatment and prevention of occupational hypersensitivity pneumonitis

In the structure of interstitial lung diseases (ILD), hypersensitive pneumonitis (HP) is quite common in the world. However, to date, the disease is often diagnosed at a late stage (fibrosis), which requires improving the methods of early diagnosis of the disease and timely examination of the connection of the disease with the profession. The analysis of domestic and foreign literature devoted to the peculiarities of the formation of a professional GP in modern socio-economic conditions is given. The authors have described the evolution of ideas about the disease, modern classification, occupational risk factors and methods of diagnosis of HP. Due to the complexity of the etiology and pathogenesis of the disease, we have drawn the attention to the need for an interdisciplinary integrated approach to the diagnosis of professional HP. The scientists have considered modern methods of treatment of the disease from the standpoint of occupational health, the prospects for improving the diagnosis, treatment and prevention of occupational HP.

Contribution:
Gorblyansky Yu.Yu. — concept and design of the study, writing the text;
Ramazanova E.R. — writing the text;
Kontorovich E.P. — writing text, editing;
Ponamareva O.P. — writing the text, bibliography design.

Funding. The study had no funding.

Conflict of interests. The authors declare no conflict of interests.

Received: 17.11.2022 / Accepted: 26.01.2023 / Published: 20.03.2023

1. Il`kovich M.M., Orlova G.P. Interstitial and orphan lung diseases. M.: GEOTAR-Media; 2016 (in Russian).

2. James P.L., Cannon J., Christopher M., Barber C.M., Crawford L. et al. Metal worker’s lung: spatial association with Mycobacterium avium. Thorax. 2018; 73(2): 151–156. https://doi.org/10.1136/thoraxjnl-2017-210226

3. McCarthy C., Keane M.P. Contemporary Concise Reviev 2021: Interstitial Lung disease. Respirology. 2022; 27(7): 539–48. https://doi.org/10.1111/resp.14278

4. Fernández Pérez E.R., Travis W.D., Lynch D.A., Brown K.K., Johannson K.A. et al. Diagnosis and Evaluation of Hypersensitivity Pneumonitis: CHEST Guideline and Expert Panel Report. Chest. 2021; 160(2): e97–e156. https://doi.org/10.1016/j.chest.2021.03.066

5. Raghu G., Remy-Jardin M., Ryerson C.J., Myers J.L., Kreuter M. et al. Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2020; 202(3): e36–e69. https://doi.org/10.1164/rccm.202005-2032ST

6. Quirce S., Vandenplas O., Campo P., Cruz M.J., de Blay F. et al. Occupational hypersensitivity pneumonitis: an EAACI position paper. Allergy. 2016; 71(6): 765–79. https://doi.org/10.1111/all.12866

7. Shumar J.N., Chandel A., King C.S. Antifibrotic Therapies and Progressive Fibrosing Interstitial Lung Disease (PF-ILD): Building on INBUILD. J Clin Med. 2021; 10(11): 2285. https://doi.org/10.3390/jcm10112285

8. Riario Sforza G.G., Marinou А. Hypersensitivity pneumonitis: a complex lung disease. Clin Mol Allergy. 2017; 15: 6. https://doi.org/10.1186/s12948-017-0062-7

9. Hsieh C., Kamangar H. Hypersensitivity Pneumonitis. Chief Editor: Byrd R.P. Updated: Jan 21, 2015. http://emedicine. medscape.com/article/299174-overview

10. Colin G., Lelong J., Tillie-Leblond I., Tonnel A.B. Pneumopathie d’hypersensibilité chez une endivière [Hypersensitivity pneumonitis in a chicory worker]. Rev Mal Respir. 2007; 24(9): 1139–42. https://doi.org/10.1016/s0761-8425(07)74265-1

11. Hines S.E., Barker E.A., Robinson M., Knight V., Gaitens J. et al. Cross-Sectional Study of Respiratory Symptoms, Spirometry, and Immunologic Sensitivity in Epoxy Resin Workers. Clin Transl Sci. 2015; 8(6): 722–8. https://doi.org/10.1111/cts.12341

12. Avdeev S.N. Hypersensitivity pneumonitis. Pulmonologiya. 2021; 31(1): 88–99 (in Russian). https://doi.org/10.18093/0869-0189-2021-31-1-88-99

13. Shmelev E.I. Exogenous allergic alveolitis. Atmosphere. Pulmonologiya i allergologiya. 2003; 4: 3–9 (in Russ.)

14. Brown K.K., Martinez F.J., Walsh S.L.F., Thannickal V.J., Prasse A. et al. The natural history of progressive fibrosing interstitial lung diseases. Eur Respir J. 2020; 55(6): 2000085. https://doi.org/10.1183/13993003.00085-2020

15. Nashatyreva M.C., Trofimenko I.N., Chernyak B.A. Clinical features of interstitial lung diseases according to data from the Irkutsk Register. Pulmonologiya. 2017; 27(6): 740–7 (in Russian). https://doi.org/10.18093/0869-0189-2017-27-6-740-747

16. Bolotova E.V., Shul’zhenko L.V., Porkhanov V.A. Pre-hospital misdiagnosis of interstitial lung disease. Pulmonologiya. 2015; 25(1): 41–4 (in Russian). https://doi.org/10.18093/0869-0189-2015-25-1-41-44

17. Vasakova M., Morell F., Walsh S., Leslie K., Raghu G. Hypersensitivity pneumonitis: perspectives in diagnosis and management. Am J Respir Crit Care Med. 2017; 196(6): 680–9. https://doi.org/10.1164/rccm.201611-2201PP

18. Hyldgaard C., Hilberg O., Muller A., Bendstrup E. A cohort study of interstitial lung diseases in central Denmark. Respir Med. 2014; 108: 793–9. https://doi.org/10.1016/j.rmed.2013.09.002

19. Wang P., Jones K.D., Urisman A., Elicker B.M., Urbania T. et al. Pathologic findings and prognosis in a large prospective cohort of chronic hypersensitivity pneumonitis. Chest. 2017; 152(3): 502–9. https://doi.org/10.1016/j.chest.2017.02.011

20. Singh S., Collins B.F., Sharma B.B., Joshi J.M., Talwar D. et al. Interstitial lung disease (ILD) in India: results of a prospective registry. Am J Respir Crit Care Med. 2017; 195(6): 801–13. https://doi.org/10.1164/rccm.201607-1484OC

21. Fernandez Perez E.R., Kong A.M., Raimundo K., Koelsch T.L., Kulkarni R., Cole A.L. Epidemiology of hypersensitivity pneumonitis among an insured population in the United States: a claims-based cohort analysis. Ann Am Thorac Soc. 2018; 15(4): 460–9. https://doi.org/10.1513/AnnalsATS.201704-288OC

22. Fernandez Perez E.R., Koelsch T.L., Leone P.M., Groshong S.D., Lynch D.A., Brown K.K. Clinical decision-making in hypersensitivity pneumonitis: diagnosis and management. Semin Respir Crit Care Med. 2020; 41(2): 214–28. https://doi.org/10.1055/s-0040-1701250

23. Barnes H., Troy L., Lee C.T., Sperling A., Strek M., Glaspole I. Hypersensitivity pneumonitis: Current concepts in pathogenesis, diagnosis, and treatment. Allergy. 2022; 77(2): 442–53. https://doi.org/10.1111/all.15017

24. Sterclova, M., Smetakova, M., Stehlik, L. Skibova J., Vasakova M. Bronchoalveolar lavage cell profiles and proteins concentrations can be used to phenotype extrinsic allergic alveolitis patients. Multidiscip Respir Med. 2019; 14: 13. https://doi.org/10.1186/s40248-019-0175-6

25. Leone P.M., Richeldi L. Current Diagnosis and Management of Hypersensitivity Pneumonitis. Tuberc Respir Dis (Seoul). 2020; 83(2): 122–31. https://doi.org/10.4046/trd.2020.0012

26. Barnes H., Olin A.C., Torén K., McSharry C., Donnelly I. et al. Occupation versus environmental factors in hypersensitivity pneumonitis: population attributable fraction. ERJ Open Res. 2020; 6(4): 00374–2020. https://doi.org/10.1183/23120541.00374-2020

27. Agache I.O., Rogozea L. Management of hypersensivity pneumonitis. Clin Transl Allergy. 2013; 3(1): 5. https://doi.org/10.1186/2045-7022-3-5

28. Kongsupon N., Walters G.I., Sadhra S.S. Occupational causes of hypersensitivity pneumonitis: a systematic review and compendium. Occup Med (Lond). 2021; 71(6–7): 255–9. https://doi.org/10.1093/occmed/kqab082

29. Spagnolo P., Rossi G., Cavazza A., Bonifazi M., Paladini I. et. al. Hypersensitivity Pneumonitis: A Comprehensive Review. J Investig Allergol Clin Immunol. 2015; 25(4): 237–50.

30. Barber C.M., Burton C.M., Hendrick D.J., Pickering C.A.C., Robertson A.S. et al. Hypersensitivity Pneumonitis in Workers Exposed to Metalworking Fluids. Am J Ind Med. 2014; 57(8): 872–80. https://doi.org/10.1002/ajim.22337

31. Rosenman K.D. Asthma, hypersensitivity pneumonitis and other respiratory diseases caused by metalworking fluids. Curr Opin Allergy Clin Immunol. 2009; 9(2): 97–102. https://doi.org/10.1097/ACI.0b013e3283229f96

32. Nogueira R., Melo N., Bastos H.N.E., Martins N., Delgado L. et al. Hypersensitivity pneumonitis: Antigen diversity and disease implications. Pulmonology. 2019; 25(2): 97–108. https://doi.org/10.1016/j.pulmoe.2018.07.003

33. Hamblin M., Prosch H., Vašáková M. Diagnosis, course and management of hypersensitivity pneumonitis. Eur Respir Rev. 2022; 31(163): 210169. https://doi.org/10.1183/16000617.0169-2021

34. Wijsenbeek M., Kreuter M., Fischer A., Mounir B., Zouad-Lejour L. et al. Non-IPF progressive fibrosing interstitial lung disease (PF-ILD): the patient journey. Am J Respir Crit Care Med. 2018; 197: A1678. https://doi.org/10.1164/ajrccm-conference.2018.197.1_MeetingAbstracts.A1678

35. Barnes H., Glaspole I.N. Progressive fibrosing hypersensitivity pneumonitis: Why wait? Respirology. 2022; 27(3): 192–3. https://doi.org/10.1111/resp.14225

36. Macaluso C., Boccabella C., Kokosi M., Sivarasan N., Kouranos V. et al. Short-term lung function changes predict mortality in patients with fibrotic hypersensitivity pneumonitis. Respirology. 2022; 27(3): 202–8. https://doi.org/10.1111/resp.14204

37. George P.M., Spagnolo P., Kreuter M., Altinisik G., Bonifazi M. et al. Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities. Lancet Respir Med. 2020; 8: 925–34. https://doi.org/10.1016/S2213-2600(20)30355-6

38. Hill M., Petnak T., Moua T. Bronchoalveolar lavage lymphocytosis in hypersensitivity pneumonitis: a retrospective cohort analysis with elimination of incorporation bias. BMC Pulm Med. 2022; 22(1): 49. https://doi.org/10.1186/s12890-022-01844-z

39. Sobiecka M., Szturmowicz M., Lewandowska K., Kowalik A., Łyżwa E. et al. Chronic hypersensitivity pneumonitis is associated with an increased risk of venous thromboembolism: a retrospective cohort study. BMC Pulm Med. 2021; 21(1): 416. https://doi.org/10.1186/s12890-021-01794-y

40. Kouranos V., Jacob J., Nicholson A., Renzoni E. Fibrotic Hypersensitivity Pneumonitis: Key Issues in Diagnosis and Management. J Clin Med. 2017; 6(6): 62. https://doi.org/10.3390/jcm6060062

41. Dias O.M., Baldi B.G., Pennati F., Aliverti A., Chate R.C. et al. Computed tomography in hypersensitivity pneumonitis: main findings, differential diagnosis and pitfalls. Expert Rev Respir Med. 2018; 12(1): 5–13. https://doi.org/10.1080/17476348.2018.1395282

42. Okabayashi H., Fukuda T., Iwasawa T., Oda T., Kitamura H. et al. The new useful high-resolution computed tomography finding for diagnosing fibrotic hypersensitivity pneumonitis: «hexagonal pattern»: a single-center retrospective study. BMC Pulm Med. 2022; 22(1): 76. https://doi.org/10.1186/s12890-022-01869-4

43. Petnak T., Thongprayoon C., Baqir M., Ryu J.H., Moua T. Antigen identification and avoidance on outcomes in fibrotic hypersensitivity pneumonitis. Eur Respir J. 2022; 60(4): 2101336. https://doi.org/10.1183/13993003.01336-2021

44. Alberti M.L., Rincon-Alvarez E., Buendia-Roldan I., Selman M. Hypersensitivity Pneumonitis: Diagnostic and Therapeutic Challenges. Front Med (Lausanne). 2021; 8: 718299. https://doi.org/10.3389/fmed.2021.718299

45. Nishida T., Kawate E., Ishiguro T., Kanauchi T., Shimizu Y., Takayanagi N. Antigen avoidance and outcome of nonfibrotic and fibrotic hypersensitivity pneumonitis. ERJ Open Res. 2021; 8(1): 00474–2021. https://doi.org/10.1183/23120541.00474-2021

46. Petnak Т., Moua T. Exposure assessment in hypersensitivity pneumonitis: a comprehensive review and proposed screening questionnaire. ERJ Open Res. 2020; 6(3): 00230–2020. https://doi.org/10.1183/23120541.00230-2020

47. Walsh S.L.F., Wells A.U., Desai S.R., Poletti V., Piciucchi S. et al. Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study. Lancet Respir Med. 2016; 4(7): 557–65. https://doi.org/10.1016/S2213-2600(16)30033-9

48. Makaryants N.N., Shmelev E.I., Lepekha L.N. New schemes in the treatment of extrinsic allergic alveolitis. Meditsinskij sovet. 2013; (1–2): 8–14 (in Russian). https://doi.org/10.21518/2079-701X-2013-1-2-8-14

49. Odinaev SH.F. Professional exogenous allergic alveolitis (prevalence, features of the current, diagnostic and therapy principles). Vestnik Akademii meditsinskikh nauk Tadzhikistana. 2019; 3(31): 314–9 (in Russian). https://doi.org/10.31712/2221-7355-2019-9-3-314-320

50. Kizimenko N.N., Litvinenko E.A., Pigarev V.N., Voropaeva Yu.A., Yakuba V.V. The increase of differentially diagnostic opportunities of computer tomography when disseminated processes in lungs. Kubanskij nauchnyj meditsinskij vestnik. 2012; 3(132): 77–81 (in Russian).

51. Tsutsui T., Miyazaki Y., Kuramochi J., Uchida K., Eishi Y., Inase N. The amount of avian antigen in household dust predicts the prognosis of chronic bird-related hypersensitivity pneumonitis. Ann Am Thorac Soc. 2015; 12(7): 1013–21. https://doi.org/10.1513/AnnalsATS.201412-569OC

52. Kizimenko N.N., Bolotova E.V., Litvinenko E.A. Comparative efficacy of radiological methods used for differencial diagnostics of interstitial lung disease. Fundamentalnye issledovaniya. 2014; 10(5): 893–6 (in Russian).

53. Schreiber T., Hadmeyer L., Randerath W. Hypersensitivity Pneumonitis – an important differential diagnosis of infiltrative lung diseases. Dtsch Med Wochenschr. 2021; 146(21): 1392–8. https://doi.org/10.1055/a-1275-6734

54. Churg A., Sin D.D., Everett D., Brown K., Cool C. Pathologic patterns and survival in chronic hypersensitivity pneumonitis. Am J Surg Pathol. 2009; 33(12): 1765–70. https://doi.org/10.1097/PAS.0b013e3181bb2538

55. Travis W.D., Costabel U., Hansell D.M. King Jr T.E., Lynch D.A. et al. An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med. 2013; 188(6): 733–48. https://doi.org/10.1164/rccm.201308-1483ST

56. Bacchus L., Shah R.D., Chung J.H., Crabtree T.P., Heitkamp D.E. et al. ACR Appropriateness Criteria® Occupational Lung Diseases. J Thorac Imaging. 2016; 31(1): W1–3. https://doi.org/10.1097/RTI.0000000000000194